Loading…

Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug

Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitro...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2012-12, Vol.58, p.214-227
Main Authors: Vega, María Celeste, Rolón, Miriam, Montero-Torres, Alina, Fonseca-Berzal, Cristina, Escario, José Antonio, Gómez-Barrio, Alicia, Gálvez, Jorge, Marrero-Ponce, Yovani, Arán, Vicente J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3
cites cdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3
container_end_page 227
container_issue
container_start_page 214
container_title European journal of medicinal chemistry
container_volume 58
creator Vega, María Celeste
Rolón, Miriam
Montero-Torres, Alina
Fonseca-Berzal, Cristina
Escario, José Antonio
Gómez-Barrio, Alicia
Gálvez, Jorge
Marrero-Ponce, Yovani
Arán, Vicente J.
description Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease. [Display omitted] ► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple.
doi_str_mv 10.1016/j.ejmech.2012.10.009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1221852850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523412006125</els_id><sourcerecordid>1221852850</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhiMEYrsLb4CQL0gcNsGexF7ngoQWFpBW4sDeLceetK4Su9hOUXkYnhWXFrhxsjz6Zv7RfFX1gtGGUSbebBvczmg2DVAGpdRQ2j-qVuxGyLoF3j2uVhSgrTm03UV1mdKWUsoFpU-rC2gZdMDkqvr59eDzBpNL12RwYQprZ_REcK-nRWcXPNHeErPBOcyYozPlr6dD4UkYifNW_wgTEovR7Qu_x9QQdg31e5eWIWWXl4yW8Nq7HMMZdz54LHkev5NdDDnkww5_z9M-O7PRa51KkI3L-ln1ZNRTwufn96p6uPvwcPupvv_y8fPtu_vatD3kWkhrRW8E9D3vuOUDM3qk46C55MaCZQJQStkB7QYEBlwY5BIYypHyTrdX1evT2LLOtwVTVrNLBqdJewxLUgzKsThITgvanVATQ0oRR7WLbtbxoBhVRzFqq05i1FHMsVrElLaX54RlmNH-bfpjogCvzoBOxcAYtTcu_ePEjWA97Qr39sRhOcfeYVTJOPQGrYtosrLB_X-TX5TtsQU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1221852850</pqid></control><display><type>article</type><title>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</title><source>ScienceDirect Freedom Collection</source><creator>Vega, María Celeste ; Rolón, Miriam ; Montero-Torres, Alina ; Fonseca-Berzal, Cristina ; Escario, José Antonio ; Gómez-Barrio, Alicia ; Gálvez, Jorge ; Marrero-Ponce, Yovani ; Arán, Vicente J.</creator><creatorcontrib>Vega, María Celeste ; Rolón, Miriam ; Montero-Torres, Alina ; Fonseca-Berzal, Cristina ; Escario, José Antonio ; Gómez-Barrio, Alicia ; Gálvez, Jorge ; Marrero-Ponce, Yovani ; Arán, Vicente J.</creatorcontrib><description>Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease. [Display omitted] ► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2012.10.009</identifier><identifier>PMID: 23124218</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier Masson SAS</publisher><subject>Antiprotozoan agents ; Biological and medical sciences ; Chagas disease ; Cluster analysis ; Cytotoxicity ; Dose-Response Relationship, Drug ; Indazoles ; Indazoles - chemical synthesis ; Indazoles - chemistry ; Indazoles - pharmacology ; Medical sciences ; Miscellaneous ; Models, Molecular ; Molecular Structure ; Parasitic Sensitivity Tests ; Pharmacology. Drug treatments ; Structure-Activity Relationship ; Structure–activity relationships ; Trypanocidal Agents - chemical synthesis ; Trypanocidal Agents - chemistry ; Trypanocidal Agents - pharmacology ; Trypanosoma cruzi - drug effects</subject><ispartof>European journal of medicinal chemistry, 2012-12, Vol.58, p.214-227</ispartof><rights>2012 Elsevier Masson SAS</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</citedby><cites>FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26761904$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23124218$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vega, María Celeste</creatorcontrib><creatorcontrib>Rolón, Miriam</creatorcontrib><creatorcontrib>Montero-Torres, Alina</creatorcontrib><creatorcontrib>Fonseca-Berzal, Cristina</creatorcontrib><creatorcontrib>Escario, José Antonio</creatorcontrib><creatorcontrib>Gómez-Barrio, Alicia</creatorcontrib><creatorcontrib>Gálvez, Jorge</creatorcontrib><creatorcontrib>Marrero-Ponce, Yovani</creatorcontrib><creatorcontrib>Arán, Vicente J.</creatorcontrib><title>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease. [Display omitted] ► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple.</description><subject>Antiprotozoan agents</subject><subject>Biological and medical sciences</subject><subject>Chagas disease</subject><subject>Cluster analysis</subject><subject>Cytotoxicity</subject><subject>Dose-Response Relationship, Drug</subject><subject>Indazoles</subject><subject>Indazoles - chemical synthesis</subject><subject>Indazoles - chemistry</subject><subject>Indazoles - pharmacology</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Parasitic Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><subject>Structure–activity relationships</subject><subject>Trypanocidal Agents - chemical synthesis</subject><subject>Trypanocidal Agents - chemistry</subject><subject>Trypanocidal Agents - pharmacology</subject><subject>Trypanosoma cruzi - drug effects</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kcGO0zAQhiMEYrsLb4CQL0gcNsGexF7ngoQWFpBW4sDeLceetK4Su9hOUXkYnhWXFrhxsjz6Zv7RfFX1gtGGUSbebBvczmg2DVAGpdRQ2j-qVuxGyLoF3j2uVhSgrTm03UV1mdKWUsoFpU-rC2gZdMDkqvr59eDzBpNL12RwYQprZ_REcK-nRWcXPNHeErPBOcyYozPlr6dD4UkYifNW_wgTEovR7Qu_x9QQdg31e5eWIWWXl4yW8Nq7HMMZdz54LHkev5NdDDnkww5_z9M-O7PRa51KkI3L-ln1ZNRTwufn96p6uPvwcPupvv_y8fPtu_vatD3kWkhrRW8E9D3vuOUDM3qk46C55MaCZQJQStkB7QYEBlwY5BIYypHyTrdX1evT2LLOtwVTVrNLBqdJewxLUgzKsThITgvanVATQ0oRR7WLbtbxoBhVRzFqq05i1FHMsVrElLaX54RlmNH-bfpjogCvzoBOxcAYtTcu_ePEjWA97Qr39sRhOcfeYVTJOPQGrYtosrLB_X-TX5TtsQU</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Vega, María Celeste</creator><creator>Rolón, Miriam</creator><creator>Montero-Torres, Alina</creator><creator>Fonseca-Berzal, Cristina</creator><creator>Escario, José Antonio</creator><creator>Gómez-Barrio, Alicia</creator><creator>Gálvez, Jorge</creator><creator>Marrero-Ponce, Yovani</creator><creator>Arán, Vicente J.</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</title><author>Vega, María Celeste ; Rolón, Miriam ; Montero-Torres, Alina ; Fonseca-Berzal, Cristina ; Escario, José Antonio ; Gómez-Barrio, Alicia ; Gálvez, Jorge ; Marrero-Ponce, Yovani ; Arán, Vicente J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antiprotozoan agents</topic><topic>Biological and medical sciences</topic><topic>Chagas disease</topic><topic>Cluster analysis</topic><topic>Cytotoxicity</topic><topic>Dose-Response Relationship, Drug</topic><topic>Indazoles</topic><topic>Indazoles - chemical synthesis</topic><topic>Indazoles - chemistry</topic><topic>Indazoles - pharmacology</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Parasitic Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><topic>Structure–activity relationships</topic><topic>Trypanocidal Agents - chemical synthesis</topic><topic>Trypanocidal Agents - chemistry</topic><topic>Trypanocidal Agents - pharmacology</topic><topic>Trypanosoma cruzi - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vega, María Celeste</creatorcontrib><creatorcontrib>Rolón, Miriam</creatorcontrib><creatorcontrib>Montero-Torres, Alina</creatorcontrib><creatorcontrib>Fonseca-Berzal, Cristina</creatorcontrib><creatorcontrib>Escario, José Antonio</creatorcontrib><creatorcontrib>Gómez-Barrio, Alicia</creatorcontrib><creatorcontrib>Gálvez, Jorge</creatorcontrib><creatorcontrib>Marrero-Ponce, Yovani</creatorcontrib><creatorcontrib>Arán, Vicente J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vega, María Celeste</au><au>Rolón, Miriam</au><au>Montero-Torres, Alina</au><au>Fonseca-Berzal, Cristina</au><au>Escario, José Antonio</au><au>Gómez-Barrio, Alicia</au><au>Gálvez, Jorge</au><au>Marrero-Ponce, Yovani</au><au>Arán, Vicente J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>58</volume><spage>214</spage><epage>227</epage><pages>214-227</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease. [Display omitted] ► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple.</abstract><cop>Kidlington</cop><pub>Elsevier Masson SAS</pub><pmid>23124218</pmid><doi>10.1016/j.ejmech.2012.10.009</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2012-12, Vol.58, p.214-227
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_1221852850
source ScienceDirect Freedom Collection
subjects Antiprotozoan agents
Biological and medical sciences
Chagas disease
Cluster analysis
Cytotoxicity
Dose-Response Relationship, Drug
Indazoles
Indazoles - chemical synthesis
Indazoles - chemistry
Indazoles - pharmacology
Medical sciences
Miscellaneous
Models, Molecular
Molecular Structure
Parasitic Sensitivity Tests
Pharmacology. Drug treatments
Structure-Activity Relationship
Structure–activity relationships
Trypanocidal Agents - chemical synthesis
Trypanocidal Agents - chemistry
Trypanocidal Agents - pharmacology
Trypanosoma cruzi - drug effects
title Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A05%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20biological%20evaluation%20and%20chemometric%20analysis%20of%20indazole%20derivatives.%201,2-Disubstituted%205-nitroindazolinones,%20new%20prototypes%20of%20antichagasic%20drug&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Vega,%20Mar%C3%ADa%20Celeste&rft.date=2012-12-01&rft.volume=58&rft.spage=214&rft.epage=227&rft.pages=214-227&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2012.10.009&rft_dat=%3Cproquest_cross%3E1221852850%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1221852850&rft_id=info:pmid/23124218&rfr_iscdi=true